| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 893.46B | 876.56B | 822.93B | 815.27B | 710.94B |
| Gross Profit | 379.98B | 381.59B | 355.34B | 319.59B | 307.32B |
| EBITDA | 135.06B | 128.97B | 103.50B | 104.51B | 128.47B |
| Net Income | 67.61B | 54.78B | 31.64B | 39.08B | 61.03B |
Balance Sheet | |||||
| Total Assets | 1.02T | 932.65B | 896.11B | 850.49B | 811.15B |
| Cash, Cash Equivalents and Short-Term Investments | 197.67B | 177.90B | 173.36B | 128.60B | 178.38B |
| Total Debt | 991.00M | 33.26B | 37.71B | 66.88B | 66.96B |
| Total Liabilities | 251.45B | 241.17B | 227.98B | 253.80B | 249.94B |
| Stockholders Equity | 763.28B | 691.39B | 668.05B | 596.62B | 561.15B |
Cash Flow | |||||
| Free Cash Flow | 78.53B | 54.24B | 103.01B | -16.76B | 45.65B |
| Operating Cash Flow | 111.00B | 90.02B | 141.03B | 14.43B | 72.25B |
| Investing Cash Flow | -42.99B | -48.15B | -42.07B | -32.20B | -57.50B |
| Financing Cash Flow | -54.63B | -34.61B | -61.58B | -36.64B | -48.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥959.21B | 13.85 | 7.77% | 3.16% | 1.93% | 25.12% | |
79 Outperform | ¥786.26B | 16.69 | 10.50% | 2.03% | 3.03% | 26.77% | |
75 Outperform | ¥4.00T | 14.47 | 7.81% | 2.07% | 5.04% | 5.98% | |
70 Outperform | ¥34.47B | 3.43 | ― | 4.37% | -2.63% | 635.00% | |
67 Neutral | ¥830.30B | 14.91 | 6.04% | 2.78% | 3.18% | 24.19% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥301.09B | 9.95 | -12.69% | 0.71% | -3.56% | ― |